Aranesp (darbepoetin alpha) solution for injections 100 mcg/ml. syringe 0.3 ml. №1

Aranesp (darbepoetin alfa) is used for the treatment of anemia, which is caused by severe pathologies. The medication can be used to treat patients from 11 years of age.

Ingredients

The active ingredient is darbepoetin alfa, which comes in the form of a syringe pre-filled with 100 micrograms of the drug.

Indications

The drug is indicated for the treatment of the following diseases:

• symptomatic anemia caused by chronic renal failure in adult patients or children from 11 years of age;

• symptomatic anemia that occurs in patients with non-myeloid malignant neoplasms during chemotherapy treatment.

Contraindications

Do not take Aranesp (darbepoetin alfa) if you have individual intolerance to the components of the drug. It is also unacceptable to use the medicine in case of hypertension.

Application and doses

Therapy with the presented drug is carried out under the supervision of a physician with experience in the treatment of cancer or kidney failure. The drug is administered intravenously or subcutaneously. For patients who are not on hemodialysis, the substance can be injected under the skin. At the beginning of treatment, the dose is 0.45 mcg / kg of body weight, which is administered once a week. If hemoglobin does not rise, a dose increase of 25% is acceptable. You can not increase more than once every 4 weeks. The hemoglobin level should not exceed 120g/l.